Latest News

October 05, 2010
A diet supplemented with powdered dried plum restored bone lost by mice during the course of normal aging, in a study led by Bernard P. Halloran, PhD, at the San Francisco VA Medical Center.
October 04, 2010
UCSF health policy expert Janet Coffman addresses some of the reasons why California is ahead of other states and the benefits of being first in health care reform.
October 04, 2010
Synuclein is a protein that can cause Parkinson’s disease, although it is not clear how. UCSF researcher Robert Edwards, MD, now has discovered that synuclein can affect signal transmission between nerve cells long before disease symptoms arise.
September 30, 2010
The National Institutes of Health (NIH) on September 30 announced 52 highly competitive awards for high-risk, high-payoff research for young biomedical scientists, and UCSF tops California institutions with four recipients.
September 29, 2010
A particularly aggressive childhood cancer can be fought successfully with far less chemotherapy than previously believed, avoiding harmful side effects caused by cancer drugs.
September 28, 2010
Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.
September 28, 2010
The UCSF Diabetes Center symposium marks its 10th anniversary.
September 27, 2010
Researchers at UCSF have been awarded a grant from the National Institutes of Health to develop a rapid, pan-viral microarray diagnostic for detecting viruses of extreme outbreak and pandemic potential.
September 24, 2010
The U.S. Department of Justice declined to consent to the University of California’s motion to intervene in Sherley v. Sebelius, the case regarding federal funding for human embryonic stem cell (hESC) research, on which UC had made a motion to the U.S. Federal Court of Appeals on Sept. 20.
September 24, 2010
Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.

Pages